Congress logo
Back to Conference page

UICC World Cancer Congress 2006

Bridging the Gap: Transforming Knowledge into Action

July 8-12, 2006, Washington, DC, USA



Sunday, 9 July 2006 - 12:00 PM
11-33

The Classification of Cancer Anorexia: A Prospective Evaluation

Mellar P. Davis, MD, FCCP, Tugba Yavuzsen, Declan Walsh, Susan LeGrand, Ruth Lagman, and Jordanka Kirkova. The Harry R. Horvitz Center for Palliative Medicine, Cleveland Clinic, 9500 Euclid Avenue, Taussig Cancer Center-Desk R35, Cleveland, OH 44195

Objective: Anorexia is commonly reported in cancer and may be evident at diagnosis. Characteristics of appetite loss include anorexia, weight loss, early satiety, and taste and smell changes. We surveyed patients with anorexia to understand the experience of anorexia and help classify the symptom complex of anorexia.

Methods:Patients prospectively completed a 22 question questionnaire. It surveyed anorexia severity, diurnal variations, gastrointestinal (GI) symptoms, taste, smell changes, and possible relationship to cancer therapy, patient concerns about their anorexia.

Results:Ninety-five patients were surveyed (mean age: 63 M/F 46/49). Anorexia was present for months in 77% (severe in constipation (58%), early satiety (82%), nausea (59%), and vomiting (50%). Other GI symptoms occurred in 32-48%. Altered food preference occurred in 57% and taste changes in 68%. Taste changes were evenly divided between sweet (15%), salt (13%), bitter (6%), and sour (3%). Altered smell occurred in 40%. 28% were not concerned about anorexia. A numerical appetite scale was related to early satiety (p=0.03), constipation (p=0.04), and vomiting (p=0.02). A numeral appetite scale negatively correlated in univariate analysis with age (r=0.13), ECOG (r=0.12), weight loss (r=0.13), number of GI symptoms (r=0.17). ECOG score (p < 0.02), the severity of appetite loss (p < 0.01) were significant factors in the numerical rating of appetite loss in multivariate analysis.

Anorexia can present without cachexia. Severe anorexia is associated with the number of GI symptoms particularly early satiety. Anti-tumor therapy worsens anorexia in most. Anorexia is a complex of primary and secondary symptoms with prominent but variable manifestations depending upon severity.


See more of Cancer Supportive Care
See more of Cancer Supportive Care

See more of The UICC World Cancer Congress 2006